Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group
Titel:
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group
Auteur:
Hingorani, Pooja Krailo, Mark Buxton, Allen Hutson, Paul Sondel, Paul M. Diccianni, Mitchell Yu, Alice Morris, Carol D. Womer, Richard B. Crompton, Brian Randall, R Lor Teot, Lisa A. DuBois, Steven G. Janeway, Katherine A. Gorlick, Richard G. Isakoff, Michael S.